APTINYX, Inc. #IPO Preview ($APTX)
Company: Aptinyx, Inc. Symbol: APTX Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Trade Date: 6/21 Shares: 5.33 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets Terms Added: 6-11-18[…]
